Working Committee for Hospital Epidemiology and Infection Control, School of Medicine, Hospital 18 das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Rua Dr Eneas de 19 Carvalho Aguiar, 255, São Paulo, SP, 05403-900, Brazil.
Centro de Laboratório Regional de Marília, Instituto Adolfo Lutz, São Paulo, Brazil.
Infection. 2022 Dec;50(6):1525-1533. doi: 10.1007/s15010-022-01839-2. Epub 2022 May 9.
Infection with carbapenem-resistant Enterobacterales (CRE) is associated with a high mortality rate in kidney transplant recipients, and colonization with CRE is one of the major risk factors for CRE infection. There is, therefore, a need to improve the capacity to detect colonization with CRE among inpatients.
In this prospective study, we compared the performance of real-time PCR for carbapenemase directly from rectal swabs with that of conventional CRE surveillance culture in all patients admitted to a kidney transplant ward between February 2019 and March 2020. Surveillance culture and real-time PCR were performed at admission and weekly until hospital discharge. Two perineum-rectal swabs were collected: one for culture and one for PCR.
We collected 905 paired samples for CRE surveillance from 399 patients, of whom 347 (87.0%) were kidney transplant recipients and 52 were waiting list patients. CRE was detected by culture and/or PCR in 75 patients (18.8%). Positivity for CRE was identified by PCR in 62 (15.5%) of the 399 patients and by culture in 55 (13.8%); 20 (5.0%) of the patients tested positive only on PCR, and 13 (3.3%) tested positive only on culture. The most common carbapenemase and species were, respectively, bla (in 85.5%) and Klebsiella pneumoniae (in 80.0%). Infection with CRE occurred in 21.6% of the colonized patients, those cases occurred only among kidney transplant recipients. None of the patients who tested negative on culture developed CRE infection.
In conclusion, the two methods are complementary and could be useful in a scenario of high CRE prevalence.
耐碳青霉烯肠杆菌科(CRE)感染与肾移植受者的高死亡率相关,而 CRE 定植是 CRE 感染的主要危险因素之一。因此,需要提高住院患者中 CRE 定植的检测能力。
在这项前瞻性研究中,我们比较了直接从直肠拭子中检测碳青霉烯酶的实时 PCR 与 2019 年 2 月至 2020 年 3 月期间所有入住肾移植病房的患者的常规 CRE 监测培养的性能。入院时和每周进行监测培养和实时 PCR,直至出院。采集两个肛周-直肠拭子:一个用于培养,一个用于 PCR。
我们从 399 名患者中收集了 905 对 CRE 监测的配对样本,其中 347 名(87.0%)为肾移植受者,52 名是候补患者。75 名患者(18.8%)通过培养和/或 PCR 检测到 CRE。399 名患者中,PCR 阳性 62 例(15.5%),培养阳性 55 例(13.8%);20 例(5.0%)患者仅 PCR 阳性,13 例(3.3%)患者仅培养阳性。最常见的碳青霉烯酶和物种分别是 bla(85.5%)和肺炎克雷伯菌(80.0%)。CRE 定植的患者中发生感染的比例为 21.6%,定植患者仅见于肾移植受者。所有培养阴性的患者均未发生 CRE 感染。
总之,这两种方法具有互补性,在 CRE 高流行的情况下可能有用。